Conor-Sedmak-Bio-Photo-1
Conor Sedmak Named Vice President of Sales at Mountain Gazette
September 26, 2024 08:00 ET | Mountain Gazette
North Lake Tahoe, CA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Conor Sedmak, formerly associate publisher of Mountain Gazette, has been named VP of Sales for the revived outdoor culture magazine. In his...
Mural_Logo.jpg
Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
September 26, 2024 07:00 ET | Mural Oncology, Inc.
Key data readouts for the company’s late-stage, potentially registrational trials of nemvaleukin are expected in late Q1/early Q2 2025 for platinum-resistant ovarian cancer and Q2 2025 for mucosal...
logo.jpg
CD47 Targeted Cancer Immunotherapy Drugs Clinical Trials FDA Approval Insight
September 26, 2024 06:09 ET | KuicK Research
Delhi, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Global CD47 Inhibitor Drug Clinical Trials Insight & Market Opportunity Outlook 2028 Report Highlights Global & Regional Market Opportunity...
The 2024 Pomegranate Industry Development Conference held in Zaozhuang City, Shandong Province -- Pomegranate Industry Shows New Vitality ZAOZHUANG, China, Sept. 26, 2024 (GLOBE NEWSWIRE) -- According to the Cyberspace Affairs Office of the CPC Zaozhuang Municipal Committee, the 2024 Pomegranate Industry Development Conference was...
KRONOS BIO NEW.jpg
Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy
September 25, 2024 08:55 ET | Kronos Bio, Inc.
– Through selective inhibition of proinflammatory transcription, p300 KAT inhibition modulates the activity and function of multiple pro-inflammatory signaling pathways that drive chronic inflammatory...
Transparency Market Research
Chronic Kidney Disease (CKD) Drugs Market is projected to reach USD 23.8 Billion, garnering a 4.2% CAGR from 2024 to 2034: Transparency Market Research, Inc.
September 24, 2024 08:32 ET | Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The global chronic kidney disease (CKD) drugs market (만성신장질환(CKD) 치료제 시장) was projected...
Mabylon AG Receives Research Grants Totaling More Than CHF 1.3 Million for Amyotrophic Lateral Sclerosis (ALS) and Inflammasome Programs
September 24, 2024 04:00 ET | AKAMPION
Schlieren, Zurich/Switzerland, September 24, 2024 - Mabylon AG, a leader in the high-throughput discovery, characterization, and development of human-derived antibodies, today announced that it has...
KRONOS BIO NEW.jpg
Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer
September 23, 2024 08:55 ET | Kronos Bio, Inc.
– New data show istisociclib (KB-0742) triggered cell death in preclinical ovarian cancer models of platinum and PARP-inhibitor (PARPi) resistance – – New PK/PD results demonstrate that istisociclib...
Alterity.png
Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
September 23, 2024 07:35 ET | ALTERITY THERAPEUTICS LIMITED
- Late Breaking Abstract and Oral Presentation on ATH434-202 Interim Phase 2 Data - - Oral Presentation on ATH434-201 Phase 2 Baseline Characteristics - MELBOURNE, Australia and SAN FRANCISCO, Sept....
SNS-INSIDER-300X300.jpg
Automotive HUD Market Size To Reach USD 5.88 Bn by 2032, Driven by Rising Demand for Safety and Advanced Driver Assistance Systems | Report by SNS Insider
September 19, 2024 06:51 ET | SNS Insider pvt ltd
Austin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The Automotive HUD Market Share is expected to reach USD 5.88 billion by the end of 2032, with a CAGR of around 16.72% during the forecast period of...